In the TOF subgroup, we noted a near-significant age difference between patients with and without advanced hepatic fibrosis.
← all excerpts
Revisiting Hepatic Fibrosis Risk in Congenital Heart Disease: Insights from Non-Invasive Markers and Echocardiography.
1
—
—